ClassID:

20524

A61K31/7052 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides

Recent Application in this class:
#301
20170326168
2017-11-16

6-aryl-9-glycosylpurines and use thereof

#302
20170313736
2017-11-02

MUTAGENIC NUCLEOSIDE ANALOGS AND USES THEREOF

#303
20170281571
2017-10-05

METHODS FOR THE TREATMENT OF ROSACEA

#304
20170274159
2017-09-28

Fluid delivery devices and methods

#305
20170267710
2017-09-21

Modulators of 5′-nucleotidase, ecto and the use thereof

#306
20170266215
2017-09-21

REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS

#307
20170258784
2017-09-14

Use of pyrroloquinoline compounds to kill clinically latent microorganisms

#308
20170253628
2017-09-07

Pyrrolopyrimidine nucleosides and analogs thereof

#309
20170253563
2017-09-07

Kinase inhibitors

#310
20170252462
2017-09-07

EXTENDED ANTEGRADE EPICARDIAL CORONARY INFUSION OF ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY

#311
20170251660
2017-09-07

Methods for treating red blood cells

#312
20170246198
2017-08-31

Process for making nucleoside phosphoramidate compounds

#313
20170246111
2017-08-31

ACTIVE-LOADED PARTICULATE MATERIALS FOR TOPICAL ADMINISTRATION

#314
20170232029
2017-08-17

Pharmaceutical anti-infective composition for inhalation

#315
20170218361
2017-08-03

Morpholino oligonucleotide manufacturing method

#316
20170216338
2017-08-03

Cancer chemotherapy employing halogenated analogs of thymidine

#317
20170197981
2017-07-13

Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

#318
20170196989
2017-07-13

RADIATION-STERILIZED BIODEGRADABLE DRUG DELIVERY COMPOSITIONS

#319
20170189547
2017-07-06

Biodegradable Drug Delivery Composition

#320
20170189439
2017-07-06

Methods for treating HCV

#321
20170189434
2017-07-06

Nicotinamide mononucleotide derivatives and their uses

#322
20170183732
2017-06-29

Transcriptional signature for chlamydial pelvic inflammatory disease

#323
20170173063
2017-06-22

Compositions and Methods for Treating an Infection

#324
20170165361
2017-06-15

TREATMENT OF LYSOSOMAL DISORDERS (ANTI-TNF THERAPY)

#325
20170143751
2017-05-25

Substituted nucleosides, nucleotides and analogs thereof

#326
20170143674
2017-05-25

Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases

#327
20170137454
2017-05-18

Pyrrolopyrimidine nucleosides and analogs thereof

#328
20170128481
2017-05-11

OCULAR TREATMENT WITH REDUCED INTRAOCULAR PRESSURE

#329
20170080006
2017-03-23

Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage

#330
20170056395
2017-03-02

Use of levocetirizine and montelukast in the treatment of traumatic injury

#331
20170049795
2017-02-23

Composition and methods of treating acne and photoaging

#332
20170044205
2017-02-16

3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV

#333
20170042925
2017-02-16

Glycoside derivatives and uses thereof

#334
20170037477
2017-02-09

System and method for diagnosis and treatment of neuropsychiatric disorders

#335
20170035792
2017-02-09

Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders

#336
20170029456
2017-02-02

Nucleotides for the treatment of liver cancer

#337
20170029378
2017-02-02

Kinase inhibitor

#338
20170027865
2017-02-02

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#339
20170007635
2017-01-12

OCULAR TREATMENT WITH REDUCED INTRAOCULAR PRESSURE

#340
20170000749
2017-01-05

Methods for Treating Cognitive Disorders Using Inhibitors of Histone Deacetylase

#341
20160361336
2016-12-15

Injectable antibiotic formulations and use thereof

#342
20160354559
2016-12-08

Fluid delivery devices and methods

#343
20160354476
2016-12-08

Targeted therapeutic nucleosides and their use

#344
20160354425
2016-12-08

METHODS FOR TREATING HCV

#345
20160346310
2016-12-01

Drug formulations

#346
20160339070
2016-11-24

Use of herbal saponins to regulate gut microflora

#347
20160304547
2016-10-20

Macrolide compound

#348
20160296546
2016-10-13

Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof

#349
20160287620
2016-10-06

Glycoclusters and their pharmaceutical use as antibacterials

#350
20160271057
2016-09-22

Aqueous suspension preparation comprising nanoparticles of macrolide antibacterial agent

#351
20160263114
2016-09-15

Compositions and methods for treating retinal degradation

#352
20160256461
2016-09-08

Methods for treating hair loss disorders

#353
20160256374
2016-09-08

Methods for treating hair loss disorders

#354
20160243148
2016-08-25

Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders

#355
20160222061
2016-08-04

Polymyxin derivatives and their use in combination therapy together with different antibiotics

#356
20160222050
2016-08-04

Mutagenic nucleoside analogs and uses thereof

#357
20160220700
2016-08-04

Method to kill pathogenic microbes in a patient

#358
20160220597
2016-08-04

Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis

#359
20160193296
2016-07-07

METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS

#360
20160184339
2016-06-30

Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells

#361
20160175483
2016-06-23

Hydrogels for vocal cord and soft tissue augmentation and repair

#362
20160166599
2016-06-16

Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient

#363
20160166597
2016-06-16

2′-branched nucleosides and flaviviridae mutation

#364
20160159843
2016-06-09

Nucleoside and nucleotide derivatives

#365
20160129035
2016-05-12

Combined anti-acid-fast bacterial agent, screening method for anti-acid-fast bacterial agents, and activity inhibitor of WecA or ortholog thereof

#366
20160102059
2016-04-14

Kinase inhibitors

#367
20160096805
2016-04-07

Kinase inhibitor

#368
20160095932
2016-04-07

Bone targeted therapeutics and methods of making and using the same

#369
20160082073
2016-03-24

Pharmaceutical composition for treating a microbial infection

#370
20160082028
2016-03-24

Biodefenses using triazole-containing macrolides

#371
20160074426
2016-03-17

Aqueous ophthalmic formulations based on azithromycin

#372
20160068839
2016-03-10

Metal-ligand coordination polymer nanoparticles and methods for making

#373
20160067324
2016-03-10

Vaccine formulation for ocular immunization

#374
20160058869
2016-03-03

Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

#375
20160058783
2016-03-03

Nucleoside and nucleotide derivatives

#376
20160058765
2016-03-03

Methods for treating hair loss disorders

#377
20160058764
2016-03-03

Methods for treating hair loss disorders

#378
20160058711
2016-03-03

Oral film-form base and preparation

#379
20160052952
2016-02-25

Substituted gemcitabine bicyclic amide analogs and treatment methods using same

#380
20160051691
2016-02-25

Carbohydrate conjugates as delivery agents for oligonucleotides

#381
20160024494
2016-01-28

COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS

#382
20160016980
2016-01-21

Methods for the preparation of diasteromerically pure phosphoramidate prodrugs

#383
20160015686
2016-01-21

Methods and compositions for increasing antibiotic activity

#384
20160000817
2016-01-07

Treatment of ocular disorders

#385
20150376724
2015-12-31

Detection of DNA sequences as risk factors for HIV infection

#386
20150374704
2015-12-31

Combined systemic and topical treatment of disordered and/or prodromal stage tissue

#387
20150361184
2015-12-17

METHODS OF MODULATING DLK STABILITY

#388
20150359813
2015-12-17

Effective treatment of esophageal adenocarcinoma using triciribine and related compounds

#389
20150352104
2015-12-10

Use of levocetirizine and montelukast in the treatment of traumatic injury

#390
20150342955
2015-12-03

Combined systemic and topical treatment of disordered tissues

#391
20150328247
2015-11-19

Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin

#392
20150328197
2015-11-19

Method and pharmaceutical composition for inhibiting PI3K/AKT/mTOR signaling pathway

#393
20150328151
2015-11-19

OPHTHALMIC DRUG DELIVERY

#394
20150322430
2015-11-12

Treatment of B-cell lymphoma with microRNA

#395
20150320883
2015-11-12

Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals

#396
20150313836
2015-11-05

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#397
20150297635
2015-10-22

Method for treating acute kidney injury

#398
20150290333
2015-10-15

PROCESS AND MATERIALS FOR MEDICAL APPLICATIONS

#399
20150283172
2015-10-08

Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process (variations)

#400
20150265647
2015-09-24

Uridine diphosphate derivatives, prodrugs, compositions and uses thereof

#401
20150259681
2015-09-17

Oligomeric compounds comprising tricyclic nucleosides and methods for their use

#402
20150245992
2015-09-03

PHARMACEUTIC OSMOTIC PUMP PREPARATION

#403
20150238520
2015-08-27

Alginate oligomers for use in overcoming multidrug resistance in bacteria

#404
20150224168
2015-08-13

Combinations with a backbone-cyclized peptide

#405
20150216886
2015-08-06

Methods for treating cancers using oral formulations of cytidine analogs

#406
20150175646
2015-06-25

Solid forms of an antiviral compound

#407
20150157591
2015-06-11

Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders

#408
20150141366
2015-05-21

Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds

#409
20150141328
2015-05-21

STIMULATION OF HUMAN MEIBOMIAN GLAND FUNCTION

#410
20150133396
2015-05-14

Compositions for treating obesity and insulin resistance disorders

#411
20150126466
2015-05-07

ANTIBACTERIAL PHARMACEUTICAL COMPOSITION

#412
20150125394
2015-05-07

METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL

#413
20150119445
2015-04-30

Carbohydrate conjugates as delivery agents for oligonucleotides

#414
20150119444
2015-04-30

Carbohydrate conjugates as delivery agents for oligonucleotides

#415
20150111845
2015-04-23

Methods for treating gastrointestinal diseases

#416
20150110767
2015-04-23

Methods for treating lung infections and inflammation

#417
20150105341
2015-04-16

Substituted nucleosides, nucleotides and analogs thereof

#418
20150105339
2015-04-16

Methods for treating resistant diseases using triazole containing macrolides

#419
20150080459
2015-03-19

Compositions containing resveratrol and nucleotides

#420
20150072948
2015-03-12

Anti-viral pyrimidine nucleoside derivatives

#421
20150065432
2015-03-05

Visfatin therapeutic agents for the treatment of acne and other conditions

#422
20150050620
2015-02-19

PREVENTING OR TREATING PERIODONTAL DISEASE

#423
20150038851
2015-02-05

Meibomian gland dysfunction

#424
20150038450
2015-02-05

Combination therapy for the treatment of cancer

#425
20150038446
2015-02-05

Compositions and methods for treating retinal degradation

#426
20150038439
2015-02-05

Method for preparing suspensions of low-solubility materials

#427
20150018300
2015-01-15

2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections

#428
20150011615
2015-01-08

Carbohydrate conjugates as delivery agents for oligonucleotides

#429
20140378401
2014-12-25

Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations

#430
20140377327
2014-12-25

Extended release drug-delivery contact lenses and methods of making

#431
20140371134
2014-12-18

Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders

#432
20140366872
2014-12-18

Aerosols for sinunasal drug delivery

#433
20140350092
2014-11-27

Method for inhibiting influenza virus infection

#434
20140348953
2014-11-27

Morphine and morphine precursors

#435
20140343003
2014-11-20

Method for treating Lyme disease

#436
20140341853
2014-11-20

Bacteria-Mediated Therapy for Cancer

#437
20140328860
2014-11-06

Methods for stimulating hematopoietic recovery by inhibiting TGFβ signaling

#438
20140323427
2014-10-30

Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis

#439
20140323425
2014-10-30

Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment

#440
20140315853
2014-10-23

Methods, formulations, and kits for rapidly repleting folate levels in women

#441
20140315849
2014-10-23

Therapeutic agent for inflammatory diseases, containing adenosine N1-oxide as an effective ingredient

#442
20140314847
2014-10-23

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS WITH IMPROVED BIOAVAILABILILTY

#443
20140308343
2014-10-16

Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof

#444
20140303107
2014-10-09

Drug formulations

#445
20140274924
2014-09-18

Concentrated aqueous azalide formulations

#446
20140242192
2014-08-28

Clusterin antisense therapy for treatment of cancer

#447
20140234302
2014-08-21

Methods and compositions for reducing amyloid beta levels

#448
20140228310
2014-08-14

Method of modulating stress-activated protein kinase system

#449
20140221305
2014-08-07

Compositions and methods for treating cancer

#450
20140194375
2014-07-10

Topical antibiotic composition for the prevention of lyme disease

#451
20140193365
2014-07-10

Biodegradable Drug Delivery Composition

#452
20140179761
2014-06-26

Targeting lipids

#453
20140162973
2014-06-12

Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

#454
20140162972
2014-06-12

Methods for treating glaucoma using uridine diphosphate derivatives

#455
20140148403
2014-05-29

Ticagrelor co-crystal

#456
20140148402
2014-05-29

Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome

#457
20140142055
2014-05-22

METHODS OF TREATING RECURRENT MEIBOMIAN GLANDS DISORDER AND THEREBY DECREASING THE FREQUENCY OF RECURRENCE

#458
20140120088
2014-05-01

AGENTS FOR THE TREATMENT OF TUMORS

#459
20140120038
2014-05-01

NANOPARTICLES FOR IMAGING AND TREATING CHLAMYDIAL INFECTION

#460
20140105936
2014-04-17

Pharmaceutical composition for the preparation of infusion solutions of antimicrobial preparations, its production process (variations)

#461
20140080778
2014-03-20

Use of secnidazole in treatment of dental infections

#462
20140073591
2014-03-13

MDR METHOD AND PRODUCTS FOR TREATING MRSA

#463
20140066395
2014-03-06

Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections

#464
20140065153
2014-03-06

Methods for treating hair loss disorders

#465
20140057869
2014-02-27

Pharmaceutical agents containing carbohydrate moieties and methods of their preparation and use

#466
20130336994
2013-12-19

Extracellular targeted drug conjugates

#467
20130324464
2013-12-05

Aryl glycoside compound, preparation method and use thereof

#468
20130310336
2013-11-21

Methods and compositions for treating flaviviruses and pestiviruses

#469
20130296228
2013-11-07

EFFLUX PUMP INHIBITORS

#470
20130295181
2013-11-07

Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof

#471
20130281686
2013-10-24

Methods for the preparation of diasteromerically pure phosphoramidate prodrugs

#472
20130281390
2013-10-24

METHOD FOR TREATING DRY EYE

#473
20130274220
2013-10-17

Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase

#474
20130274214
2013-10-17

METHOD FOR TREATING BLEPHARITIS

#475
20130273056
2013-10-17

Tyrosine-phosphorylated WBP2, a novel cancer target and biomarker

#476
20130273035
2013-10-17

Methods and compositions for reducing amyloid beta levels

#477
20130261073
2013-10-03

Modulator of activity of adenylate cyclase

#478
20130245102
2013-09-19

NOVEL DNA TEMPLATES FOR SMALL RNA PRODUCTION IN MAMMALIAN CELLS

#479
20130243886
2013-09-19

Pharmaceutical composition and method of treating a microbial infection with sulcotidil

#480
20130224218
2013-08-29

Methods and compositions for the inhibition of fructokinase

#481
20130209488
2013-08-15

Methods and compositions for malic enzyme 2 (ME2) as a target for cancer therapy

#482
20130196939
2013-08-01

Detection of DNA sequences as risk factors for HIV infection

#483
20130178441
2013-07-11

Methods for Extending Progression-Free Survival using 10-Propargyl-10-Deazaaminopterin

#484
20130172271
2013-07-04

Pharmaceutical Spray Drying

#485
20130156702
2013-06-20

Methods for the treatment and the diagnosis of cancer

#486
20130150315
2013-06-13

Anti-Protozoal for Apicomplexan Protozoa

#487
20130149314
2013-06-13

p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth

#488
20130142796
2013-06-06

TREATMENT FOR ANGIOGENIC DISORDERS

#489
20130116207
2013-05-09

Compositions and methods for treating cancer

#490
20130109645
2013-05-02

ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT AND PREVENTION OF VASCULAR OR JOINT CAPSULE CALCIFICATION DISORDERS

#491
20130109644
2013-05-02

Methods for treating cancers using oral formulations of cytidine analogs

#492
20130089551
2013-04-11

TREATMENT OF PULMONARY EDEMA

#493
20130028965
2013-01-31

RNAi therapeutic for treatment of Hepatitis C infection

#494
20130028964
2013-01-31

RNAi therapeutic for treatment of hepatitis C infection

#495
20130017993
2013-01-17

Glycoside derivatives and uses thereof

#496
20130017152
2013-01-17

METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#497
20130012469
2013-01-10

LIQUID NUCLEOTIDES/NUCLEOSIDES-CONTAINING PRODUCT

#498
20130011920
2013-01-10

Methods for reducing protein levels in a cell

#499
20120316222
2012-12-13

RNAi therapeutic for treatment of hepatitis C infection

#500
20120270827
2012-10-25

Indole Antiviral Compositions And Methods

#501
20120258924
2012-10-11

Method of modulating stress-activated protein kinase system

#502
20120251487
2012-10-04

Compounds and pharmaceutical compositions for the treatment of viral infections

#503
20120232169
2012-09-13

HIGHLY MONODISPERSE BRANCHED PEG-LIPID CONJUGATES

#504
20120231995
2012-09-13

Use of pyrroloquinoline compounds to kill clinically latent microorganisms

#505
20120225033
2012-09-06

Biodegradable Drug Delivery Composition

#506
20120202765
2012-08-09

Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds

#507
20120196272
2012-08-02

Prediction of HCV Viral Kinetics in Interferon-Free Treatment

#508
20120195975
2012-08-02

Immune stimulatory infant nutrition

#509
20120178680
2012-07-12

Glycoside derivatives and uses thereof

#510
20120149888
2012-06-14

SYNTHESIS OF ARA-2'-O-METHYL-NUCLEOSIDES, CORRESPONDING PHOSPHORAMIDITES AND OLIGONUCLEOTIDES INCORPORATING NOVEL MODIFICATIONS FOR BIOLOGICAL APPLICATION IN THERAPEUCTICS, DIAGNOSTICS, G- TETRAD FORMING OLIGONUCLEOTIDES AND APTAMERS

#511
20120142626
2012-06-07

2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections

#512
20120141505
2012-06-07

CD19-LIGAND AND USE

#513
20120136042
2012-05-31

Carbohydrate conjugates as delivery agents for oligonucleotides

#514
20120135950
2012-05-31

ANTIVIRAL TREATMENT OF LYMPHOMA AND CANCER

#515
20120129761
2012-05-24

Preparation of bone cement compositions

#516
20120122768
2012-05-17

Alginate oligomers for use in overcoming multidrug resistance in bacteria

#517
20120121702
2012-05-17

Controlled Release Azithromycin Solid Dosage Forms

#518
20120116051
2012-05-10

Polymer conjugate of bioactive substance having hydroxy group

#519
20120115803
2012-05-10

Treatment of Acinetobacter with alginate oligomers and antibiotics

#520
20120114767
2012-05-10

System and Method for Diagnosis and Treatment of Neuropsychiatric Disorders

#521
20120114663
2012-05-10

Methods to treat allergic conditions

#522
20120107300
2012-05-03

Cannabinoid Compositions and Methods

#523
20120083462
2012-04-05

Pharmaceutical anti-infective composition for inhalation

#524
20120058936
2012-03-08

COMPOSITIONS AND METHODS FOR ELIMINATION OF GRAM NEGATIVE BACTERIA

#525
20120053230
2012-03-01

Treatment of neurological disorders by dsRNA administration

#526
20120040924
2012-02-16

Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections

#527
20120040897
2012-02-16

NOVEL DERIVATIVES OF ACYL CYANOPYRROLIDINES

#528
20120039909
2012-02-16

EPIGENETIC MECHANISMS RE-ESTABLISH ACCESS TO LONG-TERM MEMORY AFTER NEURONAL LOSS

#529
20120039894
2012-02-16

Method for inhibiting dendritic cell immunoreceptor (DCIR)-mediated human immunodeficiency virus infection comprising administering anti-DCIR antibodies

#530
20120035352
2012-02-09

6-11 Bicyclic Ketolide Derivatives

#531
20120029065
2012-02-02

Compositions for treating obesity and insulin resistance disorders

#532
20120015865
2012-01-19

Class of cationic lipids for transporting active agents into cells

#533
20110306138
2011-12-15

Complex and method for enhancing nuclear delivery

#534
20110288070
2011-11-24

METHODS FOR TREATING COGNITIVE DISORDERS USING INHIBITORS OF HISTONE DEACETYLASE

#535
20110287262
2011-11-24

Polyvinyl formamide (PNVF) and polyvinyl amine (PVAm)nanoparticles, nanocapsules and nanogels

#536
20110263920
2011-10-27

Advanced methods and systems for treating cell proliferation disorders

#537
20110245190
2011-10-06

METHOD FOR IMPROVING POST SURGERY VISUAL ACUITY OUTCOME WITH AZITHROMYCIN

#538
20110237544
2011-09-29

Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use

#539
20110237534
2011-09-29

Methods for treating gastrointestinal diseases

#540
20110230654
2011-09-22

Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs

#541
20110229871
2011-09-22

NUCLEOSIDE-CONTAINING COMPOSITIONS AND METHODS FOR TREATING RED BLOOD CELLS

#542
20110213020
2011-09-01

Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria

#543
20110207664
2011-08-25

Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

#544
20110201566
2011-08-18

Methods for treating resistant diseases using triazole containing macrolides

#545
20110195920
2011-08-11

Biodefenses using triazole-containing macrolides

#546
20110178038
2011-07-21

Indole antiviral compositions and methods

#547
20110177028
2011-07-21

INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY

#548
20110171232
2011-07-14

Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth

#549
20110171159
2011-07-14

Glycoside derivatives and uses thereof

#550
20110160707
2011-06-30

Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna

#551
20110160289
2011-06-30

COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS

#552
20110152356
2011-06-23

RNAi therapeutic for treatment of hepatitis C infection

#553
20110142921
2011-06-16

RNAi therapeutic for treatment of hepatitis C infection

#554
20110142839
2011-06-16

TREATMENT OF PULMONARY EDEMA

#555
20110130356
2011-06-02

Morphine and morphine precursors

#556
20110129813
2011-06-02

2′-branched nucleosides and mutation

#557
20110110933
2011-05-12

Ectopic pregnancy treatment

#558
20110105594
2011-05-05

Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

#559
20110092570
2011-04-21

Oligomeric compounds comprising tricyclic nucelosides and methods for their use

#560
20110092488
2011-04-21

Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections

#561
20110077250
2011-03-31

COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR

#562
20110064752
2011-03-17

Extracellular targeted drug conjugates

#563
20110059180
2011-03-10

Method for Preparing Nanoparticles Based on Functional Amphiphilic Molecules or Macromolecules, and the Use Thereof

#564
20110054010
2011-03-03

Transcription factor decoys and use thereof

#565
20110027391
2011-02-03

Liquid nucleotides/nucleosides-containing product

#566
20100316576
2010-12-16

Aerosols for sinunasal drug delivery

#567
20100305054
2010-12-02

CONCENTRATED AQUEOUS AZALIDE FORMULATIONS

#568
20100291025
2010-11-18

INDAZOLE INHIBITORS OF TYROSINE KINASE

#569
20100286386
2010-11-11

Combinatorial production of nucleotide and nucleoside (XiTP) analogues

#570
20100279977
2010-11-04

Compositions and methods for treating cancer

#571
20100279967
2010-11-04

Compositions and methods for treating cancer

#572
20100279966
2010-11-04

Compositions and methods for treating cancer

#573
20100279965
2010-11-04

Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors

#574
20100249068
2010-09-30

SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS

#575
20100247666
2010-09-30

Method for Preparing Suspensions of Low-Solubility Materials

#576
20100240704
2010-09-23

METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM

#577
20100222295
2010-09-02

Anti-viral pyrimidine nucleoside derivatives

#578
20100216732
2010-08-26

Azithromycin for the treatment of nodular acne

#579
20100215634
2010-08-26

VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS

#580
20100210571
2010-08-19

TOPICAL FORMULATIONS FOR TREATMENT OF SKIN DISORDERS

#581
20100209483
2010-08-19

TRANSDERMAL DELIVERY OF MEPTAZINOL

#582
20100202969
2010-08-12

Nanoparticles for imaging and treating chlamydial infection

#583
20100190734
2010-07-29

METHOD OF TREATING DRY EYE DISEASE WITH AZITHROMYCIN

#584
20100158869
2010-06-24

Method for treatment of Huntington's disease through intracranial delivery of sirna

#585
20100137341
2010-06-03

DNA polymerase inhibitors composition and methods

#586
20100136134
2010-06-03

Immune stimulatory infant nutrition

#587
20100130574
2010-05-27

Neurodegenerative diseases and methods of modeling

#588
20100130437
2010-05-27

Topical antibiotic composition for the prevention of Lyme disease

#589
20100124554
2010-05-20

REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS

#590
20100113563
2010-05-06

Method for Treating Pain with a Calmodulin Inhibitor

#591
20100113381
2010-05-06

Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds

#592
20100111839
2010-05-06

Selective inhibitors of translesion DNA replication

#593
20100099741
2010-04-22

Molecular Targets for Treatment of Learning and Memory Dysfunction

#594
20100099635
2010-04-22

Method for treating cystic fibrosis

#595
20100093832
2010-04-15

Modulation of insulin like growth factor I receptor expression in cancer

#596
20100093650
2010-04-15

Pharmaceutical Anit-Infective Composition for Inhalation

#597
20100093634
2010-04-15

Composition and method for the treatment of hyperkalemia

#598
20100075913
2010-03-25

Pharmaceutical anti-infective composition for inhalation

#599
20100069470
2010-03-18

IDENTIFICATION OF PROTEIN BIOMARKERS ASSOCIATED WITH LYMPH NODE METASTASIS IN COLORECTAL CANCER

#600
20100069315
2010-03-18

METHOD AND MEDICAMENT FOR TREATING OCULAR INFECTIONS